{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:34:50Z","timestamp":1786649690395,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>Our aim is to compare treatment plans with vaginal markers used in radiotherapy target volume definition with those without markers, which we have not encountered in our literature searches, and to investigate whether patients with endometrial cancer (EC) can undergo treatment with a single simulation tomography.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>A total of twenty patients with EC were randomly selected. All patients underwent a computerized tomography in the supine position. During the scan, the arms were folded over the chest, and the feet were fixed with a foot immobilizer. Tomography scans were performed with a vaginal marker. A total of four treatment plans were made by a medical physicist using tomography images with both vaginal markers (CT Set 1) and 0 Hounsfield units assigned to the vaginal marker (CT Set 2) under the same conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The mean doses of maximum and mean of planning target volume (PTV) and critical organs were derived from the data obtained from the treatment plans created using CT Set 1 and CT Set 2. No significant differences were observed regarding PTV or critical organs when comparing the plans of CT Set 1 and CT Set 2 in both Treatment Planning Systems.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Dosimetric comparison of plans with and without vaginal markers, no difference was found in terms of dosimetric parameters. Therefore, we suggested that a clinical decision can be made to plan with vaginal markers, thus ensuring that the patient does not receive an unnecessary second tomography dose.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jmp.jmp_54_25","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T20:00:53Z","timestamp":1767211253000},"page":"657-662","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Investigation of the Impact of Vaginal Marker Utilization on Radiotherapy Treatment Plans Created with Various Planning Systems in Endometrial Cancer Patients"],"prefix":"10.4103","volume":"50","author":[{"given":"Hikmettin","family":"Demir","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Van Yuzuncu Yil University, Van, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berrin Benli","family":"Yavuz","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Necmettin Erbakan University, Konya, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"\u015eahin","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Necmettin Erbakan University, Konya, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"key":"R1-20260420","first-page":"405","article-title":"Conservative treatment in early stage endometrial cancer: A review","volume":"90","author":"Trojano","year":"2019","journal-title":"Acta Biomed"},{"key":"R2-20260420","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/jcp.2005.029702","article-title":"My approach to the interpretation of endometrial biopsies and curettings","volume":"59","author":"McCluggage","year":"2006","journal-title":"J Clin Pathol"},{"key":"R3-20260420","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/1097-0142(20001015)89:8<1765::AID-CNCR17>3.0.CO;2-F","article-title":"The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: A meta-analysis","volume":"89","author":"Dijkhuizen","year":"2000","journal-title":"Cancer"},{"key":"R4-20260420","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","article-title":"Endometrial cancer","volume":"387","author":"Morice","year":"2016","journal-title":"Lancet"},{"key":"R5-20260420","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijrobp.2005.10.019","article-title":"A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: Follow-up of a gynecologic oncology group study","volume":"65","author":"Rotman","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R6-20260420","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/gyno.1999.5387","article-title":"A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A gynecologic oncology group study","volume":"73","author":"Sedlis","year":"1999","journal-title":"Gynecol Oncol"},{"key":"R7-20260420","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.ijrobp.2011.05.003","article-title":"Magnitude of interfractional vaginal cuff movement: Implications for external irradiation","volume":"82","author":"Ma","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R8-20260420","doi-asserted-by":"crossref","first-page":"e645","DOI":"10.1016\/j.ijrobp.2011.01.054","article-title":"Assessment of organ motion in postoperative endometrial and cervical cancer patients treated with intensity-modulated radiation therapy","volume":"81","author":"Harris","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R9-20260420","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"International Journal of Gynecological Cancer"},{"key":"R10-20260420","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijrobp.2013.01.017","article-title":"Hematologic toxicity in RTOG 0418: A phase 2 study of postoperative IMRT for gynecologic cancer","volume":"86","author":"Klopp","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R11-20260420","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijrobp.2020.08.061","article-title":"NRG oncology\/RTOG consensus guidelines for delineation of clinical target volume for intensity modulated pelvic radiation therapy in postoperative treatment of endometrial and cervical cancer: An Update","volume":"109","author":"Small","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R12-20260420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2023.1174675","article-title":"Fiducial markers in adjuvant setting for a patient affected by endometrial cancer: a case report","volume":"13","author":"Titone","year":"2023","journal-title":"Frontiers in Oncology"},{"key":"R13-20260420","first-page":"1","article-title":"Fraction-Modulated Dose Optimization for Advanced Radiation Therapy","volume":"9","author":"Ma","year":"2024","journal-title":"Mathews Journal of Cancer Science"},{"key":"R14-20260420","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1118\/1.3598076","article-title":"Adaptive Radiation Therapy","volume":"38","author":"Allen Li","year":"2011","journal-title":"Med Phys"},{"key":"R15-20260420","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1002\/mp.12193","article-title":"Still equivalent for dose calculation in the Monte Carlo era? A comparison of free breathing and average intensity projection CT datasets for lung SBRT using three generations of dose calculation algorithms","volume":"44","author":"Zvolanek","year":"2017","journal-title":"Med Phys"},{"key":"R16-20260420","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1118\/1.2358333","article-title":"Testing of the analytical anisotropic algorithm for photon dose calculation","volume":"33","author":"Van Esch","year":"2006","journal-title":"Med Phys"},{"key":"R17-20260420","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ijrobp.2007.09.042","article-title":"Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer","volume":"71","author":"Small","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R18-20260420","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/jrr\/rrz070","article-title":"Prospective observational study on the safety of an original fiducial marker insertion for radiotherapy in gynecological cancer by a simple method","volume":"60","author":"Sekii","year":"2019","journal-title":"J Radiat Res"},{"key":"R19-20260420","first-page":"58","article-title":"The effect of contrast material in three dimensional conformal and helical treatment plans in rectal radiotherapy","volume":"20","author":"Demir","year":"2024","journal-title":"Celal Bayar Univ J Sci"},{"key":"R20-20260420","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4103\/0973-1482.131465","article-title":"Influence of the intravenous contrast media on treatment planning dose calculations of lower esophageal and rectal cancers","volume":"10","author":"Nasrollah","year":"2014","journal-title":"J Cancer Res Ther"},{"key":"R21-20260420","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.radonc.2007.05.015","article-title":"Influence of contrast materials on dose calculation in radiotherapy planning using computed tomography for tumors at various anatomical regions: A prospective study","volume":"84","author":"Shibamoto","year":"2007","journal-title":"Radiother Oncol"}],"container-title":["Journal of Medical Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jmp.jmp_54_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:57:09Z","timestamp":1786647429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jmp.jmp_54_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jmp.jmp_54_25","relation":{},"ISSN":["0971-6203","1998-3913"],"issn-type":[{"value":"0971-6203","type":"print"},{"value":"1998-3913","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"2025-02-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}